UBS Group’s Euclidean Fundamental Value ETF ECML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-751
Closed -$27.3K 10580
2026
Q1
$27.3K Sell
751
-1
-0.1% -$36 ﹤0.01% 7748
2025
Q4
$25.1K Buy
752
+630
+516% +$20.9K ﹤0.01% 7632
2025
Q3
$4.06K Sell
122
-503
-80% -$16.3K ﹤0.01% 8977
2025
Q2
$19.3K Buy
625
+578
+1,230% +$17.3K ﹤0.01% 8473
2025
Q1
$1.44K Buy
47
+15
+47% +$477 ﹤0.01% 9504
2024
Q4
$1.01K Sell
32
-54
-63% -$1.84K ﹤0.01% 9330
2024
Q3
$2.94K Sell
86
-1
-1% -$33 ﹤0.01% 8339
2024
Q2
$2.77K Buy
+87
New +$2.85K ﹤0.01% 8305
2023
Q4
Sell
-65
Closed -$1.82K 9434
2023
Q3
$1.82K Buy
+65
New +$1.84K ﹤0.01% 7823

Other funds holding ECML

UBS Group's ECML Position: Q2 2026 in Review

UBS Group sold out of Euclidean Fundamental Value ETF (ECML) in Q2 2026, closing a stake of 751 shares — an estimated $27.3K sold.

UBS Group first reported a position in ECML in Q3 2023 and held it in 9 quarters. The position peaked at $27.3K in Q1 2026. 7 funds tracked by Wall St. Rank hold ECML as of Q2 2026.

  • UBS Group reported no remaining Euclidean Fundamental Value ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 751 Euclidean Fundamental Value ETF shares in Q2 2026, an estimated $27.3K.
  • UBS Group first reported a position in Euclidean Fundamental Value ETF in Q3 2023 and held it in 9 quarters.
  • UBS Group's Euclidean Fundamental Value ETF position peaked at $27.3K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Euclidean Fundamental Value ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.